fda
Taylor Farms Spent Big on MAGA and Anti-Regulatory Lobbying Before Diarrhea Outbreak
The company donated more than $3.6 million to conservative groups between 2020 and 2025, including $1 million to the MAGA Inc. super PAC. The lettuce supplier at the center of the turbo diarrhea outbreak has spent millions of dollars to sway sentiment around food regulation and elect Donald Trump and other MAGA Republicans, according to public filings. Taylor Farms donated more than $2 million to conservative political groups in 2025, according to Federal Election Commission filings. That includes a $1 million donation to MAGA Inc., the Trump-centric super PAC, and $1.1 million to other super PACs dedicated to electing Republicans. From 2020 through the end of 2024, the company donated more than $1.6 million to conservative PACs, including a total of $850,000 to AFP Action, an anti-regulation super PAC with ties to the Koch network.
The FDA Says It Didn't Apologize to Supplier Linked to Diarrhea Outbreak, Actually
The FDA Says It Didn't Apologize to Supplier Linked to Diarrhea Outbreak, Actually The agency stressed that the July 17 voluntary recall from Taylor Farms still stands. The supplier has been linked to the ongoing cyclospora outbreak. In the middle of a diarrhea shitstorm, the Food and Drug Administration and lettuce supplier Taylor Farms appear to be facing off in a passive aggressive battle of technicalities. On July 17, the California-based company issued a voluntary recall on iceberg lettuce sourced from Central Mexico. The recall came after people across at least five states were sickened with cyclosporiasis, a parasitic infection that causes explosive diarrhea.
Wegovy maker sues rival over 'knock-off' weight-loss drugs
The maker of Ozempic and Wegovy is suing a rival firm for selling what it says are unsafe, knock-off versions of its weight-loss drugs in the US. Danish company Novo Nordisk asked US courts on Monday to ban Hims & Hers' range of weight-loss pills and injections, which it says are not approved by US authorities and infringe on its patent. The legal drama began on Friday after Hims & Hers launched a new weight-loss pill, leading to an initial threat from Novo Nordisk. Over the weekend, Hims & Hers said it would stop selling the pill. On Monday, its share price slumped as it called Novo Nordisk's decision to press ahead with the lawsuit a blatant attack.